Novartis stock dips as Q4 sales miss and 2026 guidance point to slower growth. We break down the outlook, patent risks, key drugs, valuation, and what Swiss investors should watch next.
KATX stock sees huge volume spike on 05 Feb 2026; analysis of price, volume and Meyka AI forecast
Morgan Stanley maintained Underweight and raised target; UNJCF analyst rating updated Feb 04, 2026
Raymond James maintains Outperform on Flex Ltd. Meyka AI analysis of FLEX analyst rating and $80 price target
Intraday oversold bounce on UDAICEMENT.NS stock at INR 36.23; technical setup, Meyka AI grade and price forecasts
Pre-market DG.PA stock earnings preview 05 Feb 2026: key metrics, valuation and Meyka AI forecast vs €122.55
Japan gold price whipsawed as retail demand surged, Hong Kong arbitrage surfaced, and cash heists over ¥600 million hit headlines. We explain drivers, legal risks, and practical steps for investors in
Pre-market: AADA.SW stock falls to CHF 4.19, down 7.47% on SIX; technicals, Meyka grade and forecast included
Intraday update for 9501.T stock on 05 Feb 2026: price JPY 597.40, volume 34,579,000, Meyka forecast JPY 782.79
Intraday volume surge lifts 0079.HK stock to HK$0.104 on 05 Feb 2026. See volume, technicals and Meyka AI forecast.